Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Traffic. 2010 Nov 24;12(2):162–169. doi: 10.1111/j.1600-0854.2010.01137.x

Exploitation of the Ubiquitin System by Invading Bacteria

Olivia Steele-Mortimer 1
PMCID: PMC3038682  NIHMSID: NIHMS255739  PMID: 20977569

Abstract

A variety of bacterial intracellular pathogens target the host cell ubiquitin system during invasion, a process that involves transient but fundamental changes in the actin cytoskeleton and plasma membrane. These changes are induced by bacterial proteins, which can be surface-associated, secreted or injected directly into the host cell. Here the invasion strategies of two extensively studied intracellular bacteria, Salmonella enterica serovar Typhimurium and Listeria monocytogenes, are used to illustrate some of the diverse ways by which bacterial pathogens intersect the host cell ubiquitin pathway.

Keywords: Salmonella, Listeria, effector, intracellular, type III secretion system

Introduction

Many bacterial pathogens can survive and replicate within eukaryotic host cells as well as within the extracellular environment. These facultative intracellular bacteria include important human pathogens such as; Salmonella enterica (gastroenteritis and typhoid fever), Listeria monocytogenes (listeriosis), Yersinia pestis (plague), Y. enterocolitica and Y. pseudotuberculosis (gastroenteritis), Mycobacterium tuberculosis (TB) and Legionella pneumophila (Legionnaire’s disease) amongst others. All of these bacteria can be internalized into professional phagocytes, including macrophages and dendritic cells, but some have also evolved active mechanisms to invade non-phagocytic host cells such as epithelial cells. This review focuses on the invasion mechanisms of L. monocytogenes and S. enterica serovar Typhimurium (S. Typhimurium), which invade nonphagocytic mammalian cells via strikingly different processes. L. monocytogenes uses the “zipper mechanism”, characterized by the binding of proteins on the surface of the bacteria to receptors on the surface of the host cell. In contrast, Salmonella can invade cells in the absence of specific adhesion via a process known as the “trigger mechanism”. Despite the inherent differences, the host cell ubiquitin (Ub) system is involved at multiple steps in both invasion processes. This serves as an excellent illustration of the fact that, although prokaryotes do not contain Ub, many pathogens and symbionts have developed ways to exploit this complex eukaryotic system in order to evade or utilize host cell processes.

Ubiquitination (or ubiquitylation) is a reversible, post-translational modification found in all eukaryotic cells where it plays central roles in protein degradation, membrane trafficking, signal transduction and host defense. Target proteins are modified by the covalent ligation of ubiquitin (Ub), a highly conserved 8.6 kDa protein, by a variety of linkages. Ub moieties can be added singly (mono-Ub) or in the form of chains (poly-Ub) or a combination of both. In addition, poly-Ub chains can be linear or branched, depending on whether linkage is via the same or different lysine residues in each Ub molecule. The ultimate fate of the ubiquitinated target protein is determined by the topology and length of Ub chains (1). Ub chains linked through Lys48 lead to degradation of the target via the proteasome, whereas Lys63 chains are involved in signaling and mono- or multi-ubiquitination is associated with endocytosis, sorting and other cellular pathways. Recognition of the mono-, multi-, or polyubiquitinated proteins is mediated by a diverse group of proteins containing Ub-binding domains (UBDs).

The process of ubiquitination involves the sequential activity of three classes of enzymes, designated E1, E2 and E3. In the first step the Ub activating enzyme, or E1, charges Ub in an ATP-dependent manner to form an E1-Ub thioester intermediate. The activated Ub is then transferred by a transthiolation reaction to the reactive cysteine residue of a specific E2 conjugating enzyme. Finally, an E3 Ub ligase mediates the transfer of Ub from the E2 enzyme to the target protein. Almost all E3 ligases are members of either the RING (Really Interesting New Gene), U-Box or HECT (homologous to E6-AP carboxy terminus) families, which are distinct in sequence, structure and catalytic properties [for review see (2)]. Ubiquitin-protein bonds are cleaved by a large group of proteases known as de-ubiquitinating enzymes (DUBs).

Bacterial pathogens intersect the Ub pathway at multiple points. Binding of bacterial adhesins, such as the L. moncytogenes invasins, to receptors on the host cell surface can activate signaling pathways in the host cell that involve Ub. Alternatively, many gram-negative bacterial pathogens and symbionts transfer bacterial proteins directly into host cells via specialized molecular machines, known as type III, IV or VI secretion systems (T3SS, T4SS or T6SS respectively). Proteins delivered by these systems, collectively known as effectors, often act in a coordinate fashion in order to exquisitely manipulate the host cell. Many of these bacterially encoded effectors “mimic” eukaryotic protein activities without having any significant homology at the amino acid level. Included amongst this group is the NEL (Novel E3 Ligase) family of autoregulated E3 ligases, which are translocated into host cells via T3SSs (3, 4). Although NEL proteins have no sequence or structural homology with eukaryotic E3 ligases other bacterial effectors do have structural similarity to eukaryotic ligases, such as the Salmonella HECT-like ligase SopA (5). Other bacterial effectors mimic deubiquitinases or can themselves act as substrates for host Ub-ligases (for revew see (6)).

Listeria invasion utilizes the eukaryotic Ub pathway

L. monocytogenes is a food-borne pathogen that is the causative agent of listeriosis, a serious invasive disease that primarily affects pregnant women, newborns and immunocompromised individuals (7). Two distinct pathways mediate L. monocytogenes invasion each of which is initiated by the binding of a bacterial surface protein, either internalin A (InlA) or internalin (InlB), to receptors on the surface of the host cell. In fact, either internalin alone can mediate attachment and internalization of Listeria, or internalin-coated beads, as long as the appropriate receptor is present (8, 9). Both pathways involve reorganization of the F-actin cytoskeleton, tyrosine phosphorylation and ubiquitination and are at least partially dependent on clathrin, although the signaling pathways involved are quite distinct (Figures 1 and 2) (1013).

Figure 1. InlA mediated invasion by Listeria.

Figure 1

1) InlA interacts with E-cadherin. 2) Activated Src kinase phosphorylates E-cadherin in the juxtamembrane domain causing displacement if p120. 3) Recruitment of the E3 ligase Hakai leads to polyubiquitination of E-cadherin. 4) Recruitment of clathrin and bacterial internalization.

Figure 2. InlB mediated invasion by Listeria.

Figure 2

1) Ligand mediated dimerization of Met and autophosphorylation. 2) Recruitment of Cbl monoubiquitylation of Met. 3) Recruitment of endocytic machinery and internalization of Listeria

InlA-mediated invasion

The surface-bound protein InlA binds to E-cadherin, a single-pass transmembrane protein that functions as a Ca2+-dependent, homophilic cell–cell adhesion molecule that forms a physical link between the cell membranes of adjacent cells (14). The cytoplasmic tail of E-cadherin interacts directly with two catenins, p120- and β-catenin, initiating the formation of the cadherin–catenin complex, which also includes α-catenin and the actin-binding protein EPLIN (1518). Internalization of E-cadherin is important for maintaining cellular homeostasis but it is inhibited when p120 is bound to the juxtamembrane (JMD) domain of E-cadherin since this prevents association of the E3 Ub ligase Hakai and components of the endocytic machinery (19, 20).

In epithelial cells the E-cadherin complex is endocytosed following activation of the tyrosine kinase Src, which induces tyrosine phosphorylation and ubiquitination of E-cadherin (19). Internalized E-cadherin is either trafficked to late endosomes and lysosomes for degradation (21) or recycled back to the cell surface with the exocyst (22). Ubiquitination of E-cadherin at the cell surface is dependent on Hakai, which interacts with E-cadherin in a tyrosine phosphorylation-dependent manner (19). Similarly, InlA-mediated internalization of Listeria induces sequential Src-dependent phosphorylation and Hakai-dependent ubiquitination of E-cadherin (10, 23), ultimately resulting in an accumulation of clathrin at the site of entry (10). Intriguingly InlA also binds to another cell surface pool of E-cadherin that co-localizes with caveolin in cholesterol-rich domains, however, although this binding can induce invasion it has no requirement for tyrosine phosphorylation or ubiquitination of E-cadherin (10).

InlB-mediated invasion

The host cell receptor for InlB is the receptor tyrosine kinase (RTK) Met (24) that regulates epithelial remodeling, dispersal, and invasion (25). This disulfide-linked heterodimer has an extracellular region composed of a Sema domain, a cysteine-rich domain, and four immunoglobulin-like domains (26). InlB interacts tightly with the first immunoglobulin-like domain of the Met stalk, a domain which does not bind HGF and second contact between InlB and the Met Sema domain locks the receptor in a rigid, signaling competent conformation (27). However, even though InlB is not a structural mimic of HGF, binding of either ligand to Met induces strikingly similar events including; receptor dimerization and autophosphorylation and downstream signaling events involving Grb2, Gab1, phosphatidylinositol 3-kinase and MAP kinase (MAPK) (2832). Indeed, HGF can even substitute for InlB in inducing bacterial uptake (30). One possible distinguishing feature is the role of CD44, the hyaluronic acid transmembrane receptor, which is critical in HGF induced, but not InlB induced, Met pathways (33).

Acute stimulation of the Met receptor leads to receptor internalization into clathrin-coated vesicles and its down-regulation. This process requires the E3 Ub ligase Cbl, which targets Met for ubiquitination and degradation (34). Cbl binds to Met via a DpYR motif in the cytoplasmic domain of the RTK(35). Binding of InlB induces the Cbl-dependent monoubiquitination and endocytosis of Met and over-expression or down-regulation of Cbl, increases or decreases bacterial invasion, respectively (12). Thus Cbl has an essential role in InlB-mediated invasion and this is dependent on the endocytic machinery since RNA interference-mediated knock-down of major components of the endocytic machinery (clathrin, dynamin, eps15, Grb2, CIN85, CD2AP, cortactin and Hrs) inhibit bacterial entry (12).

Although the primary receptor for InlB is Met several other cell surface proteins, including the RTK gC1qR (receptor for complement component C1q) (36) and glycosaminoglycans (37) have been shown to act as co-receptors during bacterial entry. Binding of InlB to gC1qR stimulates tyrosine phosphorylation of the adaptor proteins Gab1, Cbl and Shc and activation of phosphatidyl inositol 3-kinase (36). This interaction is specific and invasion can be inhibited by addition of anti-gC1qR antibodies or C1q (36). In fact, gC1qR interacts with and facilitates entry of numerous microbial and parasitic pathogens, including Staphylococcus aureus as well as Plasmodium falciparum and HIV (38). How gC1q-R transduces signals into the cell is unclear since it has no transmembrane domain, and it is likely that interactions with Met, or an alternative membrane bound protein, are required. One potential candidate is β1-integrin, an interesting possibility since β1-and β3-integrins have been shown to be required for efficient InlB-mediated invasion (39, 40).

The bacterial toxin Listeriolysin O is down-modulated by ubiquitination

Many Gram-positive bacterial pathogens secrete water-soluble toxins, or cytolysins, that bind to target cell membranes and form multi-molecular transmembrane pores (for review see (41)). Apart from their pore forming ability cytolysins have other activities that can affect a variety of functions in host cells. Listeriolysin O (LLO), a cholesterol-dependent pore-forming toxin, plays an essential role in the escape of L. monocytogenes from the phagosome into the host cell cytoplasm. LLO also induces NF-κB signaling in a pore-forming-independent manner, by inducing dephosphorylation of histone H3 and deacetylation of histone H4 (42), and impairs the sumoylation pathway (43). These activities are shared by a number of bacterial toxins (42, 43) and it is apparent that, if not regulated appropriately, they have the potential to do more harm than good for the pathogen. This is certainly true for LLO, which is ubiquitinated and targeted for proteolysis during replication of cytosolic L. monocytogenes. Strains overproducing LLO or producing LLO with a stabilizing mutation have increased toxicity for host cells and have a significant virulence defect (44, 45).

Salmonella triggers the Ub pathway

S. Typhimurium is a common cause of gastroenteritis in humans The ability to invade nonphagocytic cells, such as enterocytes in the intestinal epithelium, is an essential virulence determinant and is dependent on a T3SS, T3SS1. A second, functionally distinct T3SS, T3SS2, is required for post-invasion establishment of the replicative niche, a modified phagosome known as the Salmonella-containing vacuole (SCV) [for review see (46)]. Invasion is initiated when a cohort of T3SS1 effectors is translocated across the plasma membrane and into the cytosol of the host cell. The coordinated activity of at least three of these effectors leads to localized and transient changes in the actin cytoskeleton resulting in the formation of plasma membrane ruffles and engulfment of the bacteria [for review see (47)]. Several Salmonella effectors, from both T3SS1 and T3SS2, intersect the host cell Ub-pathway, although here the focus will be on T3SS1 effectors because of their role in invasion (Figure 3).

Figure 3. Salmonella T3SS1effectors that intersect the eukaryotic ubiquitin system.

Figure 3

See text for details.

T3SS1 effectors are substrates for the eukaryotic Ub pathway

Salmonella uses the host cell Ub system to ensure sequential activity of the T3SS1 effector proteins, SopE and SptP. SopE is the prototypical member of a family of guanine nucleotide exchange factor (GEF) mimics used by bacterial enteropathogens to activate Rho GTPases (48, 49). SopE and SopE-like GEFs are functional mimics of host cell GEFs since they have no structural or sequence identity yet function similarly by catalyzing the exchange of GDP for GTP thus switching the GTPase to its active state (48). SopE stimulates nucleotide exchange Cdc42 and Rac1, resulting in the actin polymerization necessary for invasion (50). To ensure that this actin polymerization is switched off following internalization, Salmonella translocates a GAP protein, SptP, which catalyzes the hydrolysis of GTP thus returning the GTPase to its inactive state (51, 52). The sequential activity of SopE and SptP, which are translocated simultaneously by T3SS1, is determined by ubiquitination following translocation. Both effectors are ubiquitinated and targeted to the proteosome, but SopE is degraded more efficiently and therefore inactivated more rapidly than SptP (51). This is an example of the exquisite interaction between the pathogen and host, where activation of a host protein, in this case Cdc42, is temporally controlled to stimulate the ruffles required for invasion and then switched off so that the actin cytoskeleton and membrane can rapidly revert to normal state.

Another T3SS1 effector that is ubiquitinated following translocation into host cells is SopB (also known as SigD), an inositol phosphate phosphatase that has several functions during invasion and for some time thereafter (5356). Initially translocated SopB associates with the plasma membrane where it contributes to invasion by indirectly activating SGEF, an exchange factor for RhoG, which is involved in actin remodeling (53). Following invasion, SopB is translocated across the SCV membrane where it reduces the levels of negatively charged lipids thus playing a role in SCV maturation (56). SopB is monoubiquitinated on at least six lysine residues following translocation into host cells via an unknown mechanism that does not require any of the known Salmonella E3 Ub ligases (57, 58). Ubiquitination down-regulates SopB activity at the plasma membrane and increases retention of the effector on the SCV, thus expanding the functional repertoire of SopB, since the same enzymatic activity can be used to modulate actin-mediated bacterial internalization and Akt activation at the plasma membrane as well as vesicular trafficking and intracellular bacterial replication at the phagosome (57, 58).

A Salmonella HECT-like E3 ligase

SopA is one of several T3SS1 effectors with no defined function, although it does contribute to invasion in polarized cells (59). Based on functional and structural data SopA appears to be a novel HECT-like E3 ligase, even though it has very little sequence similarity with any eukaryotic E3 ligases. In vitro it forms an ubiquitin-thioester intermediate (5, 60) and analysis of the crystal structure of SopA revealed a C-terminal domain that has a bilobal architecture reminiscent of the N- and C-lobe arrangement of HECT domains (5, 60). The C-lobe of SopA is almost twice as large as a canonical C-lobe, 170 compared to 100 amino acids, but it has the conformational flexibility that is an important characteristic of HECT ligases (5, 60). A putative substrate-binding site, adjacent to the E2 binding domain, is a β-helix cylinder containing a sugar-binding site, suggesting that SopA may recognize carbohydrate-modified substrate proteins, although no substrates have been identified thus far (60). An additional interesting feature of SopA is that it is targeted for degradation following ubiquitination by the ER-bound RING finger protein 5 (RNF5/RMA1) (61), a protein better known for its role as part of the ER-anchored Ub ligase complex, which processes malfolded proteins (62, 63).

The NEL ligases

NEL family members, with conserved primary sequences and domain architecture, have been identified in a variety of gram-negative bacteria including Salmonella, Yersina and Shigella (64, 65). All are characterized by the presence of an NEL domain, containing a conserved catalytic cysteine residue, that is believed to mediate E2 binding and the ubiquitination reaction (66). Many also contain a leucine-rich repeat (LRR) of variable length that is likely a substrate recognition module (66). Intriguingly, LRR motifs are present in many mammalian proteins, including TLR4 (Toll Like Receptor 4), that are used to detect pathogen-associated molecular patterns (67). This has lead to the suggestion that molecular mimicry of this group of eukaryotic proteins could enable NEL ligases to subvert the immune response (64).

Three Salmonella effectors SlrP, SspH1 and SspH2, are NEL family members. All have been implicated in pathogenesis, even though SspH1 has limited distribution among S. enterica serotypes compared to SlrP and SspH2, which are widely distributed (68, 69). SspH2 is translocated by T3SS2 (68, 70) and is therefore unlikely to be involved in invasion per se, however, SlrP and SspH1 are members of a small group of “promiscuous” effectors that can be translocated into host cells via both T3SS1 and T3SS2 indicating that they may have roles both early and late in infection (68, 71). The NEL domains from these proteins have no structural resemblance to any mammalian ligases, but they have robust E3 ligase activity when combined in vitro with the human E2 ligase UbcH5 (3, 66). The catalytic mechanism of these ligases is distinct from that of the HECT E3 ligases, or SopA, since there is no thioester intermediate (66). In addition, studies on SspH2, have shown that the LRR domain appears to sequester the catalytic cysteine residue in the NEL domain such that activation of these ligases requires a substantial conformational change. Ultimately, binding of the LRR domain to proteins at the target site may be required to release the ligase domain for site-specific function (66). A surprising feature of SspH2 directed poly-Ub chain synthesis is that it results in the accumulation of K48-linked poly-Ub chains directly tethered to the E2 UBcH5 (65). Thus SspH2 may transfer completed poly-Ub chains from UbcH5 to the target protein (65).

Two hybrid systems have been used to identify eukaryotic binding partners of the Salmonella NEL effectors (70, 72, 73). SspH1 has been shown to interact with a fatty acid- and Rho-activated serine/threonine protein kinase called protein kinase N 1 (PKN1) (70), whereas thioredoxin and the endoplasmic reticulum protein ERdj3 were identified as SlrP binding partners (72, 73). The significance to Salmonella pathogenesis is unclear, since effector mediated ubiquitination of these substrates has only been shown in vitro (3, 72, 73).

Deubiquitination

S. Typhimurium has two T3 effectors, SseL and AvrA, which have been shown to have deubiquitinase activity and appear to be involved in down-regulating immune signaling (7477). SseL is translocated via T3SS2 and is not likely to be involved in invasion, but AvrA is translocated by T3SS1 and has been shown to have a role in invasion in vivo (75). AvrA is a close homolog of YopJ a Y. pestis and Y. pseudotuberculosis effector that negatively regulates NF-κB and MAPK signaling (76, 78). The anti inflammatory effects of YopJ and AvrA may occur via slightly different mechanisms (76) but both have been shown to deubiquitinate a number of proteins such as IκB-α and β-catenin suggesting that they regulate host inflammatory responses through NF-κB and β-catenin pathways (79, 80). It has also been suggested that inhibition of β-catenin Ub might occur when AvrA blocks an E3 ligase such as β-TrCP (79). Recently the relevance of some of these studies was brought under scrutiny since AvrA does not seem to have significant anti-inflammatory effects when translocated by Salmonella at endogenous levels (81). Indeed, the role of AvrA and YopJ as DUBs is unclear since both have also been shown to function as acetyltransferases (8285).

A common DUB thread in invasion mechanisms

Although the invasion mechanisms used by S. Typhimurium and L. monocytogenes are very different they both require extensive actin remodeling and factors that modulate actin dynamics in the host cell can affect invasion. One such factor that was recently described is Ubiquitin C-terminal hydrolase –L1 (UCHL1), a member of the UCH class of DUBs that is associated with neurodegenerative conditions, including Parkinsons disease, and a wide range of malignancies (86). UCHL1 up-regulates β-catenin signaling (87) and possibly promotes invasion of both Salmonella and Listeria by modulating actin dynamics in the host cell (86).

Conclusions

Bacteria do not possess Ub, yet many bacterial pathogens successfully utilize or intersect the host cell Ub pathway during invasion and establishment of the intracellular niche as well as for immune modulation (for review see (88)). Here only the initial invasion process has been considered, yet it goes without saying that the ability to exploit the omnipresent ubiquitin pathway is a powerful adaption that provides bacterial pathogens with the potential to access a myriad of cellular pathways.

Acknowledgments

Work in the Steele-Mortimer laboratory is funded by the Intramural Research Program (DIR) of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. I would like to thank the members of the laboratory and the anonymous reviewer for their constructive criticism and suggestions.

References

  • 1.Ikeda F, Dikic I. Atypical ubiquitin chains: new molecular signals. ‘Protein Modifications: Beyond the Usual Suspects’ review series. EMBO Rep. 2008;9(6):536–542. doi: 10.1038/embor.2008.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Nagy V, Dikic I. Ubiquitin ligase complexes: from substrate selectivity to conjugational specificity. Biol Chem. 2010;391(2–3):163–169. doi: 10.1515/bc.2010.021. [DOI] [PubMed] [Google Scholar]
  • 3.Rohde JR, Breitkreutz A, Chenal A, Sansonetti PJ, Parsot C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe. 2007;1(1):77–83. doi: 10.1016/j.chom.2007.02.002. [DOI] [PubMed] [Google Scholar]
  • 4.Zhu Y, Li H, Hu L, Wang J, Zhou Y, Pang Z, Liu L, Shao F. Structure of a Shigella effector reveals a new class of ubiquitin ligases. Nat Struct Mol Biol. 2008;15(12):1302–1308. doi: 10.1038/nsmb.1517. [DOI] [PubMed] [Google Scholar]
  • 5.Zhang Y, Higashide WM, McCormick BA, Chen J, Zhou D. The inflammation-associated Salmonella SopA is a HECT-like E3 ubiquitin ligase. Mol Microbiol. 2006;62(3):786–793. doi: 10.1111/j.1365-2958.2006.05407.x. [DOI] [PubMed] [Google Scholar]
  • 6.Collins CA, Brown EJ. Cytosol as battleground: ubiquitin as a weapon for both host and pathogen. Trends Cell Biol. 2010;20(4):205–213. doi: 10.1016/j.tcb.2010.01.002. [DOI] [PubMed] [Google Scholar]
  • 7.Bonazzi M, Lecuit M, Cossart P. Listeria monocytogenes internalin and E-cadherin: from bench to bedside. Cold Spring Harb Perspect Biol. 2009;1(4):a003087. doi: 10.1101/cshperspect.a003087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lecuit M, Dramsi S, Gottardi C, Fedor-Chaiken M, Gumbiner B, Cossart P. A single amino acid in E-cadherin responsible for host specificity towards the human pathogen Listeria monocytogenes. EMBO J. 1999;18(14):3956–3963. doi: 10.1093/emboj/18.14.3956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Braun L, Nato F, Payrastre B, Mazie JC, Cossart P. The 213-amino-acid leucine-rich repeat region of the listeria monocytogenes InlB protein is sufficient for entry into mammalian cells, stimulation of PI 3-kinase and membrane ruffling. Mol Microbiol. 1999;34(1):10–23. doi: 10.1046/j.1365-2958.1999.01560.x. [DOI] [PubMed] [Google Scholar]
  • 10.Bonazzi M, Veiga E, Pizarro-Cerda J, Cossart P. Successive post-translational modifications of E-cadherin are required for InlA-mediated internalization of Listeria monocytogenes. Cell Microbiol. 2008;10(11):2208–2222. doi: 10.1111/j.1462-5822.2008.01200.x. [DOI] [PubMed] [Google Scholar]
  • 11.Cossart P, Lecuit M. Interactions of Listeria monocytogenes with mammalian cells during entry and actin-based movement: bacterial factors, cellular ligands and signaling. The EMBO journal. 1998;17(14):3797–3806. doi: 10.1093/emboj/17.14.3797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Veiga E, Cossart P. Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells. Nat Cell Biol. 2005;7(9):894–900. doi: 10.1038/ncb1292. [DOI] [PubMed] [Google Scholar]
  • 13.Veiga E, Guttman JA, Bonazzi M, Boucrot E, Toledo-Arana A, Lin AE, Enninga J, Pizarro-Cerda J, Finlay BB, Kirchhausen T, Cossart P. Invasive and adherent bacterial pathogens coOpt host clathrin for infection. Cell Host Microbe. 2007;2(5):340–351. doi: 10.1016/j.chom.2007.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mengaud J, Ohayon H, Gounon P, Mege RM, Cossart P. E-cadherin is the receptor for internalin, a surface protein required for entry of L. monocytogenes into epithelial cells. Cell. 1996;84(6):923–932. doi: 10.1016/s0092-8674(00)81070-3. [DOI] [PubMed] [Google Scholar]
  • 15.Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z. Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol. 1994;14(12):8333–8342. doi: 10.1128/mcb.14.12.8333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Watabe M, Nagafuchi A, Tsukita S, Takeichi M. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol. 1994;127(1):247–256. doi: 10.1083/jcb.127.1.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hirano S, Kimoto N, Shimoyama Y, Hirohashi S, Takeichi M. Identification of a neural alpha-catenin as a key regulator of cadherin function and multicellular organization. Cell. 1992;70(2):293–301. doi: 10.1016/0092-8674(92)90103-j. [DOI] [PubMed] [Google Scholar]
  • 18.Abe K, Takeichi M. EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt. Proc Natl Acad Sci U S A. 2008;105(1):13–19. doi: 10.1073/pnas.0710504105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, Sommer T, Birchmeier W. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol. 2002;4(3):222–231. doi: 10.1038/ncb758. [DOI] [PubMed] [Google Scholar]
  • 20.Miyashita Y, Ozawa M. Increased internalization of p120-uncoupled E-cadherin and a requirement for a dileucine motif in the cytoplasmic domain for endocytosis of the protein. J Biol Chem. 2007;282(15):11540–11548. doi: 10.1074/jbc.M608351200. [DOI] [PubMed] [Google Scholar]
  • 21.Palacios F, Tushir JS, Fujita Y, D’SouzaSchorey C. Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol. 2005;25(1):389–402. doi: 10.1128/MCB.25.1.389-402.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Langevin J, Morgan MJ, Sibarita JB, Aresta S, Murthy M, Schwarz T, Camonis J, Bellaiche Y. Drosophila exocyst components Sec5, Sec6, and Sec15 regulate DE-Cadherin trafficking from recycling endosomes to the plasma membrane. Dev Cell. 2005;9(3):365–376. doi: 10.1016/j.devcel.2005.07.013. [DOI] [PubMed] [Google Scholar]
  • 23.Sousa S, Cabanes D, Bougneres L, Lecuit M, Sansonetti P, Tran-Van-Nhieu G, Cossart P. Src, cortactin and Arp2/3 complex are required for E-cadherin-mediated internalization of Listeria into cells. Cell Microbiol. 2007;9(11):2629–2643. doi: 10.1111/j.1462-5822.2007.00984.x. [DOI] [PubMed] [Google Scholar]
  • 24.Shen Y, Naujokas M, Park M, Ireton K. InIB-dependent internalization of Listeria is mediated by the Met receptor tyrosine kinase. Cell. 2000;103(3):501–510. doi: 10.1016/s0092-8674(00)00141-0. [DOI] [PubMed] [Google Scholar]
  • 25.Lai AZ, Abella JV, Park M. Crosstalk in Met receptor oncogenesis. Trends Cell Biol. 2009;19(10):542–551. doi: 10.1016/j.tcb.2009.07.002. [DOI] [PubMed] [Google Scholar]
  • 26.Gherardi E, Sandin S, Petoukhov MV, Finch J, Youles ME, Ofverstedt LG, Miguel RN, Blundell TL, Vande Woude GF, Skoglund U, Svergun DI. Structural basis of hepatocyte growth factor/scatter factor and MET signalling. Proc Natl Acad Sci U S A. 2006;103(11):4046–4051. doi: 10.1073/pnas.0509040103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Niemann HH, Jager V, Butler PJ, van den Heuvel J, Schmidt S, Ferraris D, Gherardi E, Heinz DW. Structure of the human receptor tyrosine kinase met in complex with the Listeria invasion protein InlB. Cell. 2007;130(2):235–246. doi: 10.1016/j.cell.2007.05.037. [DOI] [PubMed] [Google Scholar]
  • 28.Ireton K, Payrastre B, Chap H, Ogawa W, Sakaue H, Kasuga M, Cossart P. A role for phosphoinositide 3-kinase in bacterial invasion. Science. 1996;274(5288):780–782. doi: 10.1126/science.274.5288.780. [DOI] [PubMed] [Google Scholar]
  • 29.Ireton K, Payrastre B, Cossart P. The Listeria monocytogenes protein InlB is an agonist of mammalian phosphoinositide 3-kinase. J Biol Chem. 1999;274(24):17025–17032. doi: 10.1074/jbc.274.24.17025. [DOI] [PubMed] [Google Scholar]
  • 30.Banerjee M, Copp J, Vuga D, Marino M, Chapman T, van der Geer P, Ghosh P. GW domains of the Listeria monocytogenes invasion protein InlB are required for potentiation of Met activation. Mol Microbiol. 2004;52(1):257–271. doi: 10.1111/j.1365-2958.2003.03968.x. [DOI] [PubMed] [Google Scholar]
  • 31.Copp J, Marino M, Banerjee M, Ghosh P, van der Geer P. Multiple regions of internalin B contribute to its ability to turn on the Rasmitogen-activated protein kinase pathway. J Biol Chem. 2003;278(10):7783–7789. doi: 10.1074/jbc.M211666200. [DOI] [PubMed] [Google Scholar]
  • 32.Reinl T, Nimtz M, Hundertmark C, Johl T, Keri G, Wehland J, Daub H, Jansch L. Quantitative phosphokinome analysis of the Met pathway activated by the invasin internalin B from Listeria monocytogenes. Mol Cell Proteomics. 2009;8(12):2778–2795. doi: 10.1074/mcp.M800521-MCP200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Dortet L, Veiga E, Bonazzi M, Cossart P. CD44-independent activation of the Met signaling pathway by HGF and InlB. Microbes Infect. 2010 doi: 10.1016/j.micinf.2010.07.009. [DOI] [PubMed] [Google Scholar]
  • 34.Peschard P, Fournier TM, Lamorte L, Naujokas MA, Band H, Langdon WY, Park M. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol Cell. 2001;8(5):995–1004. doi: 10.1016/s1097-2765(01)00378-1. [DOI] [PubMed] [Google Scholar]
  • 35.Peschard P, Ishiyama N, Lin T, Lipkowitz S, Park M. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. J Biol Chem. 2004;279(28):29565–29571. doi: 10.1074/jbc.M403954200. [DOI] [PubMed] [Google Scholar]
  • 36.Braun L, Ghebrehiwet B, Cossart P. gC1q-R/p32, a C1q-binding protein, is a receptor for the InlB invasion protein of Listeria monocytogenes. EMBO J. 2000;19(7):1458–1466. doi: 10.1093/emboj/19.7.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Jonquieres R, Pizarro-Cerda J, Cossart P. Synergy between the N- and C-terminal domains of InlB for efficient invasion of non-phagocytic cells by Listeria monocytogenes. Mol Microbiol. 2001;42(4):955–965. doi: 10.1046/j.1365-2958.2001.02704.x. [DOI] [PubMed] [Google Scholar]
  • 38.Fausther-Bovendo H, Vieillard V, Sagan S, Bismuth G, Debre P. HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway. PLoS Pathog. 2010;6:e1000975. doi: 10.1371/journal.ppat.1000975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Feng X, Tonnesen MG, Peerschke EI, Ghebrehiwet B. Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol. 2002;168(5):2441–2448. doi: 10.4049/jimmunol.168.5.2441. [DOI] [PubMed] [Google Scholar]
  • 40.Auriemma C, Viscardi M, Tafuri S, Pavone LM, Capuano F, Rinaldi L, Della Morte R, Iovane G, Staiano N. Integrin receptors play a role in the internalin B-dependent entry of Listeria monocytogenes into host cells. Cell Mol Biol Lett. 2010;15(3):496–506. doi: 10.2478/s11658-010-0019-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Heuck AP, Moe PC, Johnson BB, editors. The cholesterol-dependent cytolysin family of gram-positive bacterial toxins. 2010/03/10. 2010. [DOI] [PubMed] [Google Scholar]
  • 42.Hamon MA, Batsche E, Regnault B, Tham TN, Seveau S, Muchardt C, Cossart P. Histone modifications induced by a family of bacterial toxins. Proc Natl Acad Sci U S A. 2007;104(33):13467–13472. doi: 10.1073/pnas.0702729104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ribet D, Hamon M, Gouin E, Nahori MA, Impens F, Neyret-Kahn H, Gevaert K, Vandekerckhove J, Dejean A, Cossart P. Listeria monocytogenes impairs SUMOylation for efficient infection. Nature. 2010;464(7292):1192–1195. doi: 10.1038/nature08963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Schnupf P, Zhou J, Varshavsky A, Portnoy DA. Listeriolysin O secreted by Listeria monocytogenes into the host cell cytosol is degraded by the N-end rule pathway. Infect Immun. 2007;75(11):5135–5147. doi: 10.1128/IAI.00164-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Schnupf P, Hofmann J, Norseen J, Glomski IJ, Schwartzstein H, Decatur AL. Regulated translation of listeriolysin O controls virulence of Listeria monocytogenes. Mol Microbiol. 2006;61(4):999–1012. doi: 10.1111/j.1365-2958.2006.05286.x. [DOI] [PubMed] [Google Scholar]
  • 46.Steele-Mortimer O. The Salmonella-containing vacuole: moving with the times. Curr Opin Microbiol. 2008;11(1):38–45. doi: 10.1016/j.mib.2008.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Schlumberger MC, Hardt WD. Salmonella type III secretion effectors: pulling the host cell’s strings. Curr Opin Microbiol. 2006;9(1):46–54. doi: 10.1016/j.mib.2005.12.006. [DOI] [PubMed] [Google Scholar]
  • 48.Huang Z, Sutton SE, Wallenfang AJ, Orchard RC, Wu X, Feng Y, Chai J, Alto NM. Structural insights into host GTPase isoform selection by a family of bacterial GEF mimics. Nat Struct Mol Biol. 2009;16(8):853–860. doi: 10.1038/nsmb.1647. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Buchwald G, Friebel A, Galan JE, Hardt WD, Wittinghofer A, Scheffzek K. Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J. 2002;21(13):3286–3295. doi: 10.1093/emboj/cdf329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Hardt WD, Chen LM, Schuebel KE, Bustelo XR, Galan JE. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell. 1998;93(5):815–826. doi: 10.1016/s0092-8674(00)81442-7. [DOI] [PubMed] [Google Scholar]
  • 51.Kubori T, Galan JE. Temporal regulation of salmonella virulence effector function by proteasome-dependent protein degradation. Cell. 2003;115(3):333–342. doi: 10.1016/s0092-8674(03)00849-3. [DOI] [PubMed] [Google Scholar]
  • 52.Fu Y, Galan JE. A salmonella protein antagonizes Rac-1 and Cdc42 to mediate host-cell recovery after bacterial invasion. Nature. 1999;401(6750):293–297. doi: 10.1038/45829. [DOI] [PubMed] [Google Scholar]
  • 53.Patel JC, Galan JE. Differential activation and function of Rho GTPases during Salmonella-host cell interactions. J Cell Biol. 2006;175(3):453–463. doi: 10.1083/jcb.200605144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Steele-Mortimer O, Knodler LA, Marcus SL, Scheid MP, Goh B, Pfeifer CG, Duronio V, Finlay BB. Activation of Akt/protein kinase B in epithelial cells by the Salmonella typhimurium effector sigD. J Biol Chem. 2000;275(48):37718–37724. doi: 10.1074/jbc.M008187200. [DOI] [PubMed] [Google Scholar]
  • 55.Knodler LA, Finlay BB, Steele-Mortimer O. The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt. J Biol Chem. 2005;280(10):9058–9064. doi: 10.1074/jbc.M412588200. [DOI] [PubMed] [Google Scholar]
  • 56.Bakowski MA, Braun V, Lam GY, Yeung T, Do Heo W, Meyer T, Finlay BB, Grinstein S, Brumell JH. The phosphoinositide phosphatase SopB manipulates membrane surface charge and trafficking of the Salmonella-containing vacuole. Cell Host Microbe. 2010;7(6):453–462. doi: 10.1016/j.chom.2010.05.011. [DOI] [PubMed] [Google Scholar]
  • 57.Patel JC, Hueffer K, Lam TT, Galan JE. Diversification of a Salmonella virulence protein function by ubiquitin-dependent differential localization. Cell. 2009;137(2):283–294. doi: 10.1016/j.cell.2009.01.056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Knodler LA, Winfree S, Drecktrah D, Ireland R, Steele-Mortimer O. Ubiquitination of the bacterial inositol phosphatase, SopB, regulates its biological activity at the plasma membrane. Cell Microbiol. 2009;11(11):1652–1670. doi: 10.1111/j.1462-5822.2009.01356.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Raffatellu M, Wilson RP, Chessa D, Andrews-Polymenis H, Tran QT, Lawhon S, Khare S, Adams LG, Baumler AJ. SipA, SopA, SopB, SopD, and SopE2 contribute to Salmonella enterica serotype typhimurium invasion of epithelial cells. Infect Immun. 2005;73(1):146–154. doi: 10.1128/IAI.73.1.146-154.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Diao J, Zhang Y, Huibregtse JM, Zhou D, Chen J. Crystal structure of SopA, a Salmonella effector protein mimicking a eukaryotic ubiquitin ligase. Nat Struct Mol Biol. 2008;15(1):65–70. doi: 10.1038/nsmb1346. [DOI] [PubMed] [Google Scholar]
  • 61.Zhang Y, Higashide W, Dai S, Sherman DM, Zhou D. Recognition and ubiquitination of Salmonella type III effector SopA by a ubiquitin E3 ligase, HsRMA1. J Biol Chem. 2005;280(46):38682–38688. doi: 10.1074/jbc.M506309200. [DOI] [PubMed] [Google Scholar]
  • 62.Younger JM, Chen L, Ren HY, Rosser MF, Turnbull EL, Fan CY, Patterson C, Cyr DM. Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator. Cell. 2006;126(3):571–582. doi: 10.1016/j.cell.2006.06.041. [DOI] [PubMed] [Google Scholar]
  • 63.Delaunay A, Bromberg KD, Hayashi Y, Mirabella M, Burch D, Kirkwood B, Serra C, Malicdan MC, Mizisin AP, Morosetti R, Broccolini A, Guo LT, Jones SN, Lira SA, Puri PL, et al. The ER-bound RING finger protein 5 (RNF5/RMA1) causes degenerative myopathy in transgenic mice and is deregulated in inclusion body myositis. PLoS One. 2008;3(2):e1609. doi: 10.1371/journal.pone.0001609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Soundararajan V, Patel N, Subramanian V, Sasisekharan V, Sasisekharan R. The many faces of the YopM effector from plague causative bacterium Yersinia pestis and its implications for host immune modulation. Innate Immun. 2010 doi: 10.1177/1753425910377099. [DOI] [PubMed] [Google Scholar]
  • 65.Levin I, Eakin C, Blanc MP, Klevit RE, Miller SI, Brzovic PS. Identification of an unconventional E3 binding surface on the UbcH5 ~ Ub conjugate recognized by a pathogenic bacterial E3 ligase. Proc Natl Acad Sci U S A. 2010;107(7):2848–2853. doi: 10.1073/pnas.0914821107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Quezada CM, Hicks SW, Galan JE, Stebbins CE. A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases. Proc Natl Acad Sci U S A. 2009;106(12):4864–4869. doi: 10.1073/pnas.0811058106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Ng AC, Eisenberg JM, Heath RJ, Huett A, Robinson CM, Nau GJ, Xavier RJ. Microbes and Health Sackler Colloquium: Human leucine-rich repeat proteins: a genome-wide bioinformatic categorization and functional analysis in innate immunity. Proc Natl Acad Sci U S A. 2010 doi: 10.1073/pnas.1000093107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Miao EA, Scherer CA, Tsolis RM, Kingsley RA, Adams LG, Baumler AJ, Miller SI. Salmonella typhimurium leucine-rich repeat proteins are targeted to the SPI1 and SPI2 type III secretion systems. Mol Microbiol. 1999;34(4):850–864. doi: 10.1046/j.1365-2958.1999.01651.x. [DOI] [PubMed] [Google Scholar]
  • 69.Tsolis RM, Townsend SM, Miao EA, Miller SI, Ficht TA, Adams LG, Baumler AJ. Identification of a putative Salmonella enterica serotype typhimurium host range factor with homology to IpaH and YopM by signature-tagged mutagenesis. Infect Immun. 1999;67(12):6385–6393. doi: 10.1128/iai.67.12.6385-6393.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Haraga A, Miller SI. A Salmonella type III secretion effector interacts with the mammalian serine/threonine protein kinase PKN1. Cell Microbiol. 2006;8(5):837–846. doi: 10.1111/j.1462-5822.2005.00670.x. [DOI] [PubMed] [Google Scholar]
  • 71.Miao EA, Miller SI. A conserved amino acid sequence directing intracellular type III secretion by Salmonella typhimurium. Proc Natl Acad Sci U S A. 2000;97(13):7539–7544. doi: 10.1073/pnas.97.13.7539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Bernal-Bayard J, Cardenal-Munoz E, Ramos-Morales F. The Salmonella type III secretion effector, salmonella leucine-rich repeat protein (SlrP), targets the human chaperone ERdj3. J Biol Chem. 2010;285(21):16360–16368. doi: 10.1074/jbc.M110.100669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Bernal-Bayard J, Ramos-Morales F. Salmonella type III secretion effector SlrP is an E3 ubiquitin ligase for mammalian thioredoxin. J Biol Chem. 2009;284(40):27587–27595. doi: 10.1074/jbc.M109.010363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Le Negrate G, Faustin B, Welsh K, Loeffler M, Krajewska M, Hasegawa P, Mukherjee S, Orth K, Krajewski S, Godzik A, Guiney DG, Reed JC. Salmonella secreted factor L deubiquitinase of Salmonella typhimurium inhibits NF-kappaB, suppresses IkappaBalpha ubiquitination and modulates innate immune responses. J Immunol. 2008;180(7):5045–5056. doi: 10.4049/jimmunol.180.7.5045. [DOI] [PubMed] [Google Scholar]
  • 75.Lu R, Wu S, Liu X, Xia Y, Zhang YG, Sun J. Chronic effects of a Salmonella type III secretion effector protein AvrA in vivo. PLoS One. 2010;5(5):e10505. doi: 10.1371/journal.pone.0010505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Collier-Hyams LS, Zeng H, Sun J, Tomlinson AD, Bao ZQ, Chen H, Madara JL, Orth K, Neish AS. Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-kappa B pathway. J Immunol. 2002;169(6):2846–2850. doi: 10.4049/jimmunol.169.6.2846. [DOI] [PubMed] [Google Scholar]
  • 77.Liao AP, Petrof EO, Kuppireddi S, Zhao Y, Xia Y, Claud EC, Sun J. Salmonella type III effector AvrA stabilizes cell tight junctions to inhibit inflammation in intestinal epithelial cells. PLoS One. 2008;3(6):e2369. doi: 10.1371/journal.pone.0002369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Zhou H, Monack DM, Kayagaki N, Wertz I, Yin J, Wolf B, Dixit VM. Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J Exp Med. 2005;202(10):1327–1332. doi: 10.1084/jem.20051194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Sun J, Hobert ME, Rao AS, Neish AS, Madara JL. Bacterial activation of beta-catenin signaling in human epithelia. Am J Physiol Gastrointest Liver Physiol. 2004;287(1):G220–227. doi: 10.1152/ajpgi.00498.2003. [DOI] [PubMed] [Google Scholar]
  • 80.Ye Z, Petrof EO, Boone D, Claud EC, Sun J. Salmonella effector AvrA regulation of colonic epithelial cell inflammation by deubiquitination. Am J Pathol. 2007;171(3):882–892. doi: 10.2353/ajpath.2007.070220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Du F, Galan JE. Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog. 2009;5(9):e1000595. doi: 10.1371/journal.ppat.1000595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Jones RM, Wu H, Wentworth C, Luo L, Collier-Hyams L, Neish AS. Salmonella AvrA Coordinates Suppression of Host Immune and Apoptotic Defenses via JNK Pathway Blockade. Cell Host Microbe. 2008;3(4):233–244. doi: 10.1016/j.chom.2008.02.016. [DOI] [PubMed] [Google Scholar]
  • 83.Wu S, Ye Z, Liu X, Zhao Y, Xia Y, Steiner A, Petrof EO, Claud EC, Sun J. Salmonella typhimurium infection increases p53 acetylation in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2010;298(5):G784–794. doi: 10.1152/ajpgi.00526.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, Orth K. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science. 2006;312(5777):1211–1214. doi: 10.1126/science.1126867. [DOI] [PubMed] [Google Scholar]
  • 85.Mittal R, Peak-Chew SY, Sade RS, Vallis Y, McMahon HT. The acetyltransferase activity of the bacterial toxin YopJ of Yersinia is activated by eukaryotic host cell inositol hexakisphosphate. J Biol Chem. 2010;285(26):19927–19934. doi: 10.1074/jbc.M110.126581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Basseres E, Coppotelli G, Pfirrmann T, Andersen JB, Masucci M, Frisan T. The ubiquitin C-terminal hydrolase UCH-L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton. Cell Microbiol. 2010 doi: 10.1111/j.1462-5822.2010.01495.x. [DOI] [PubMed] [Google Scholar]
  • 87.Bheda A, Yue W, Gullapalli A, Whitehurst C, Liu R, Pagano JS, Shackelford J. Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling. PLoS One. 2009;4(6):e5955. doi: 10.1371/journal.pone.0005955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Spallek T, Robatzek S, Gohre V. How microbes utilize host ubiquitination. Cell Microbiol. 2009;11(10):1425–1434. doi: 10.1111/j.1462-5822.2009.01346.x. [DOI] [PubMed] [Google Scholar]

RESOURCES